Accelerate Diagnostics Inc. Finalizes Asset Sale Amidst Chapter 11 Liquidation Process
I'm PortAI, I can summarize articles.
Accelerate Diagnostics, Inc. has finalized an asset sale as part of its Chapter 11 liquidation process. The U.S. Bankruptcy Court confirmed the company's restructuring plan on August 13, 2025. The agreement with Indaba Capital Management involves selling specific assets and liabilities, with the effective date expected around August 18, 2025. This move is part of the Amended and Restated Asset Purchase Agreement, aimed at implementing the outlined transactions.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments